March 27, 2023

Halozyme Therapeutics (HALO) went from a darling to a dog it had a patent issue in Europe and pricing pressure in the US.

December 7, 2022

Halozyme Therapeutics’ (HALO) Enhanze makes other drugs easy to absorb, while HALO makes royalties on the sales of those drugs.

September 15, 2022

Halozyme Therapeutics (HALO) is a Biotech stock that’s popped up on my radar recently. But is this stock worth the risk? Let’s see.

July 13, 2022

Halozyme Therapeutics (HALO is emerging as a stock market leader. The company makes it easier for drugs to be absorbed in the body.

March 21, 2023

Halozyme Therapeutics (HALO) is expected to report qtrly profits (EPS) and revenues:

Profits Estimates: $0.50 vs. $0.47 = +6%
Revenue Est: +54%